Search

Your search keyword '"Nason, Martha"' showing total 328 results

Search Constraints

Start Over You searched for: Author "Nason, Martha" Remove constraint Author: "Nason, Martha" Language english Remove constraint Language: english
328 results on '"Nason, Martha"'

Search Results

1. Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

2. Risk of COVID-19 after natural infection or vaccination

3. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

4. Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial

5. Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.

6. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

7. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

8. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity

10. Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern Mexico

11. Changing interim monitoring in response to internal clinical trial data.

12. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

13. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease

15. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

17. Rapid development of a DNA vaccine for Zika virus

19. Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency

22. Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

23. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

24. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

26. Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire

27. Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization

28. A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.

29. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

34. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

37. A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

38. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression

39. Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV

45. Decreased CD127 expression on T cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy

49. PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors.

Catalog

Books, media, physical & digital resources